DOUBLE-HIT LYMPHOMA
Clinical trials for DOUBLE-HIT LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new DOUBLE-HIT LYMPHOMA trials appear
Sign up with your email to follow new studies for DOUBLE-HIT LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New cocktail aims to tackle tough lymphoma
Disease control Not yet recruitingThis early-stage trial tests whether adding sonrotoclax to standard Pola-R-CHP chemotherapy can improve outcomes for people with untreated large B-cell lymphoma that has high BCL2 expression or double-hit features. The study has two parts: first, finding a safe dose of sonrotocla…
Matched conditions: DOUBLE-HIT LYMPHOMA
Phase: PHASE1, PHASE2 • Sponsor: Ruijin Hospital • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
New cell therapy aims to wipe out lingering lymphoma before it returns
Disease control Not yet recruitingThis early-phase trial tests a personalized cell therapy (rapcabtagene autoleucel) in 20 adults with large B-cell lymphoma who still have traces of cancer after initial treatment. The goal is to see if the therapy can make those traces disappear, potentially lowering the risk of …
Matched conditions: DOUBLE-HIT LYMPHOMA
Phase: PHASE1 • Sponsor: Stanford University • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC